Table 1 Humoral immune-response profile of the presence of binding antibodies and type I autoantibodies of the volunteers.
From: The oldest unvaccinated Covid-19 survivors in South America
BINDING ANTIBODIES AGAINST SARS-CoV-2* | |||||
Participants | ID 01 | ID 02 | ID 03 | ||
Covid-19 episode | Symptomatic | Asymptomatic | Symptomatic | ||
Specific SARS-CoV-2antibodies (Ratio) | IgA | NP | - (0.0) | - (0.2) | - (0.9) |
RBD | - (0.1) | - (0.5) | + (5.4) | ||
IgM | NP | - (0.3) | - (0.0) | - (0.1) | |
RBD | - (0.5) | + (1.5) | - (0.7) | ||
IgG | NP | + (1.3) | + (3.1) | + (9.5) | |
RBD | + (4.2) | + (3.1) | + (7.8) | ||
TYPE I IFN AUTOANTIBODIES | |||||
Auto-anti IFNS IFN-α2, IFN-β and/or -ω (Ratio) | - (0.0) | - (0.0) | - (0.0) | ||